1
|
International Federation of Psoriasis
Associations: World Psoriasis Day, 2015. https://ifpa-pso.com/our-actions/world-psoriasis-day.
Accessed June 27, 2019.
|
2
|
Griffiths CEM, van der Walt JM, Ashcroft
DM, Flohr C, Naldi L, Nijsten T and Augustin M: The global state of
psoriasis disease epidemiology: A workshop report. Br J Dermatol.
177:e4–e7. 2017.PubMed/NCBI View Article : Google Scholar
|
3
|
Bolognia J, Jorizzo JL and Schaffer JV
(eds): Dermatology. Elsevier Saunders, Philadelphia, PA, 2012.
|
4
|
Ayala-Fontánez N, Soler DC and McCormick
TS: Current knowledge on psoriasis and autoimmune diseases.
Psoriasis (Auckl). 6:7–32. 2016.PubMed/NCBI View Article : Google Scholar
|
5
|
McFadden J, Valdimarsson H and Fry L:
Cross-reactivity between streptococcal M surface antigen and human
skin. Br J Dermatol. 125:443–447. 1991.PubMed/NCBI View Article : Google Scholar
|
6
|
Narang T, Dogra S, Kaur I and Kanwar AJ:
Malassezia and psoriasis: Koebner's phenomenon or direct causation?
J Eur Acad Dermatol Venereol. 21:1111–1112. 2007.PubMed/NCBI View Article : Google Scholar
|
7
|
Enerbäck C, Martinsson T, Inerot A,
Wahlström J, Enlund F, Yhr M and Swanbeck G: Evidence that HLA-Cw6
determines early onset of psoriasis, obtained using
sequence-specific primers (PCR-SSP). Acta Derm Venereol.
77:273–276. 1997.PubMed/NCBI View Article : Google Scholar
|
8
|
Raychaudhuri SK, Maverakis E and
Raychaudhuri SP: Diagnosis and classification of psoriasis.
Autoimmun Rev. 13:490–495. 2014.PubMed/NCBI View Article : Google Scholar
|
9
|
Spencer JM and Hadi SM: The excimer
lasers. J Drugs Dermatol. 3:522–525. 2004.PubMed/NCBI
|
10
|
Mehraban S and Feily A: 308 nm excimer
laser in dermatology. J Lasers Med Sci. 5:8–12. 2014.PubMed/NCBI
|
11
|
Mavilia L, Mori M, Rossi R, Campolmi P,
Puglisi Guerra A and Lotti T: 308 nm monochromatic excimer light in
dermatology: Personal experience and review of the literature. G
Ital Dermatol Venereol. 143:329–337. 2008.PubMed/NCBI
|
12
|
Morita A, Weiss M and Maeda A: Recent
developments in phototherapy: Treatment methods and devices. Recent
Pat Inflamm Allergy Drug Discov. 2:105–108. 2008.PubMed/NCBI View Article : Google Scholar
|
13
|
Abrouk M, Levin E, Brodsky M, Gandy JR,
Nakamura M, Zhu TH, Farahnik B, Koo J and Bhutani T: Excimer laser
for the treatment of psoriasis: safety, efficacy, and patient
acceptability. Psoriasis (Auckl). 6:165–173. 2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Taneja A, Trehan M and Taylor CR: 308-nm
excimer laser for the treatment of psoriasis: Induration-based
dosimetry. Arch Dermatol. 139:759–764. 2003.PubMed/NCBI View Article : Google Scholar
|
15
|
Mudigonda T, Dabade TS and Feldman SR: A
review of protocols for 308 nm excimer laser phototherapy in
psoriasis. J Drugs Dermatol. 11:92–97. 2012.PubMed/NCBI
|
16
|
Kemény L, Bónis B, Dobozy A, Bor Z, Szabó
G and Ignácz F: 308-nm excimer laser therapy for psoriasis. Arch
Dermatol. 137:95–96. 2001.PubMed/NCBI
|
17
|
Tatu AL, Ciobotaru OR, Miulescu M, Buzia
OD, Elisei AH, Mardarea N, Diaconu C, Robu S and Nwabudike LC:
Hydrochlorothiazide: Chemical structure, therapeutic, phototoxic
and carcinogenetic effects in dermatology Rev. Chim. 69:2110–2114.
2018.
|
18
|
Nwabudike LC and Tatu AL: Response to -
chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32:e159. 2018.PubMed/NCBI View Article : Google Scholar
|
19
|
Tatu AL, Ionescu MA and Nwabudike LC:
Contact allergy to topical momethasone furoate confirmed by
rechallenge and patch test. Am J Ther. 25:e497–e498.
2018.PubMed/NCBI View Article : Google Scholar
|
20
|
Gheorghe I, Tatu AL, Lupu I, Thamer O,
Cotar AI, Pircalabioru GG, Popa M, Cristea VC, Lazar V and
Chifiriuc MC: Molecular characterization of virulence and
resistance features in Staphylococcus aureus clinical strains
isolated from cutaneous lesions in patients with drug adverse
reactions. Rom Biotechnol Lett. 22:12321–12327. 2017.
|
21
|
Tatu AL and Nwabudike LC: Reply to: Kubiak
K, et al: Endosymbiosis and its significance in dermatology.
J Eur Acad Dermatol Venereol. 32:e346–e347. 2018.PubMed/NCBI View Article : Google Scholar
|
22
|
Tatu AL and Cristea VC: Pityriasis
folliculorum of the back thoracic area: Pityrosporum, keratin
plugs, or Demodex involved? J Cutan Med Surg.
21(441)2017.PubMed/NCBI View Article : Google Scholar
|
23
|
Buzia OD, Fasie V, Mardare N, Diaconu C,
Gurau G and Tatu AL: Formulation, preparation, physico-chimical
analysis, microbiological peculiarities and therapeutic challenges
of extractive solution of Kombucha. Rev Chim. 69:720–724. 2018.
|
24
|
Tatu AL and Cristea VC: Unilateral
blepharitis with fine follicular scaling. J Cutan Med Surg.
21(442)2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Irimie M, Oanţă A, Irimie CA, Fekete LG,
Minea DI and Pascu A: Cardiovascular risk factors in patients with
chronic plaque psoriasis: A case-control study on the Brasov County
population. Acta Dermatovenerol Croat. 23:28–35. 2015.PubMed/NCBI
|
26
|
Nwabudike LC and Tatu AL: Using
complementary and alternative medicine for the treatment of
psoriasis: A step in the right direction. JAMA Dermatol.
155(636)2019.PubMed/NCBI View Article : Google Scholar
|
27
|
Nwabudike LC and Tatu AL: Response to:
Murphy EC, Nussbaum D, Prussick R, Friedman AJ. Use of
complementary and alternative medicine by patients with psoriasis.
J Am Acad Dermatol. 81(e105)2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Modrigan M, Draganescu M, Condratovici CP,
Pavel LL and Condratovici AP: Clinical personality patterns in
young adults with HIV nosocomial infection from the region of
Southeast Romania Mater. Plast. 54:175–179. 2017.
|
29
|
Batani A, Brănișteanu DE, Ilie MA, Boda D,
Ianosi S, Ianosi G and Caruntu C: Assessment of dermal papillary
and microvascular parameters in psoriasis vulgaris using in vivo
reflectance confocal microscopy. Exp Ther Med. 15:1241–1246.
2018.PubMed/NCBI View Article : Google Scholar
|